Trisomy 7 and deletion of the 9p21 locus as novel acquired abnormalities in a case of pediatric biphenotypic acute leukemia

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 3, 2012, Pages

  Tarsitano, Marina ^a   Leszl, Anna ^c   Parasole, Rosanna ^b   Cavaliere, Maria Luigia ^a   Menna, Giuseppe ^b   Di Meglio, Annamaria ^c   Buldini, Barbara ^c   Poggi, Vincenzo ^b   Vicari, Laura ^a  

^a CARDARELLI HOSPITAL   (Italy)

^b SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CLOFARABINE; CYCLOPHOSPHAMIDE; CYTARABINE; FLUDARABINE; IDARUBICIN; MELPHALAN; NELARABINE;

ACUTE BIPHENOTYPIC LEUKEMIA; ANEMIA; CASE REPORT; CHILD; CHROMOSOME 9P; CHROMOSOME 9P21; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; GENE DELETION; GENE LOCUS; HUMAN; HYPERLEUKOCYTOSIS; LETTER; LEUKOCYTOSIS; LYMPHADENOPATHY; MEDIASTINUM DISEASE; MEDIASTINUM LYMPHADENOPATHY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; TRISOMY 7;

CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; KARYOTYPING; LEUKEMIA, BIPHENOTYPIC, ACUTE; SEQUENCE DELETION; TRISOMY;

EID: 84859218323     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182387ee0     Document Type: Letter

References (9)

1. Al-Seraihy AS, Owaidah TM, Ayas M, et al. Clinical characteristics and outcome of children with biphenotypic acute leukemia. Haematologica. 2009;94:1682-1690.
2. Mejstrikova E, Volejnikova J, Fronkova E, et al. Prognosis of children with mixed phenotype acute leukemia treated in accordance with consistent immunophenotypic criteria. Haematologica. 2010;95:928-935.
3. Van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901-1928.
4. Bené MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias European Group for the International Characterization of Leukemias (EGIL). Leukemia. 1995;10:1783-1786.
5. Flohr T, Scrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOPBFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia. 2008;22:771-782. (Pubitemid 351552626)
6. Libermann TA, Nusbaum HR, Razon N, et al. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. J Cell Sci. 1985;suppl 3):161-172.
7. Houldsworth J, Cordon-Cardo C, Ladanyi M, et al. Gene amplification in gastric and esophageal adenocarcinomas. Cancer Res. 1990;50:6417-6422. (Pubitemid 20323708)
8. Usvasalo A, Ninomiya S, Räty R, et al. Focal 9pinstability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses. Genes Chromosomes Cancer. 2010;49:309-318.
9. Okuda T, Shurtleff SA, Valentine MB, et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood. 1995;85:2321-2330.